View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Hilde Van Boxstael ... (+7)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Michiel Declercq
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
Nicolas McBeath
  • Nicolas McBeath

Avanza Bank (Buy, TP: SEK300.00) - Do not discount Sweden yet

The threat of a growth slowdown for Avanza is probably overstated by the market, with fiscal and monetary policy tailwinds set to support still-robust growth in savings in Sweden for 2025–2026e. We have upgraded to BUY (HOLD), raised our target price to SEK300 (255) and our 2025–2026e EPS by 4–6% (6–9% above consensus).

Coloplast AS: 1 director

A director at Coloplast AS bought 45,700 shares at 875.000DKK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

 PRESS RELEASE

Coloplast A/S - Finanskalender 2024-25

Coloplast A/S - Finanskalender 2024-25 Venligst se vedlagte pdf. For yderligere information og kalenderinvitationer til kommende begivenheder, besøg venligst:  Med venlig hilsen,Investor RelationsColoplast A/STel. 4911 1800   For yderligere information, kontakt venligst Investorer og analytikereAnders Lonning-SkovgaardKoncerndirektør, CFOTlf. 4911 1111 Aleksandra DimovskaVice President, Investor RelationsTlf. 4911 1800 / 4911 2458E-mail: Kristine Husted MunkSenior Manager, Investor RelationsTlf. 4911 1800 / 4911 3266E-mail: Presse og medierPeter MønsterSr. ...

 PRESS RELEASE

Coloplast A/S - Financial Calendar 2024-25

Coloplast A/S - Financial Calendar 2024-25 Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit:  Kind regards,Investor RelationsColoplast A/STel.   For further information, please contact Investors and analystsAnders Lonning-SkovgaardExecutive Vice President, CFOTel. Aleksandra DimovskaVice President, Investor RelationsTel. / Email: Kristine Husted MunkSenior Manager, Investor RelationsTel. / Email: Press and mediaPeter MønsterSr. Media Relations ManagerTel. Email: AddressColoplast A/SHoltedam 1DK-3050 Humleb...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf. Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf. Attachment

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf. Attachment

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment

 PRESS RELEASE

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments. Per September 6, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,289,066 shares, corresponding to 4.97% (previously 5.00%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial ins...

Kristof Samoy
  • Kristof Samoy

CMB.Tech Market court ruling opening door to $0.52 MTO bid price incre...

In a press release Euronav (soon to be renamed CMB.TECH) informed that the Market Court in Belgium has largely rejected the claims brought forward by FourWorld in connection with CMB's mandatory public bid for the Euronav shares that ended March 15, 2024. However, the Court did find that the pricing of certain vessels sold by Euronav to Frontline implied certain special benefits to Frontline. The Court calculated these benefits to be $0.52 p.s.. The judgment indicates that the FSMA retains discr...

Hilde Van Boxstael ... (+4)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Wim Lewi
Jørgen Lian
  • Jørgen Lian

Euronav (Hold, TP: USD16.30) - Charting a new course

Crude tankers remain the main earnings driver for now, but Euronav is steadily steering towards diversified shipping, with particular focus on sustainable solutions. A by-product of this is increasingly diversified cash flows supporting through-the-cycle investments – but also significant capex needs potentially straining the balance sheet and curtailing shareholder distributions medium-term. We reiterate our HOLD and have lowered our target price to USD16.3 (17.9).

 PRESS RELEASE

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments. Per September 2, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,377,683 shares, corresponding to 4.99% (previously 5.12%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial instr...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch